Corbin Capital Partners, L.P. Roivant Sciences Ltd. Transaction History
Corbin Capital Partners, L.P.
- $65.7 Million
- Q3 2024
A detailed history of Corbin Capital Partners, L.P. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Corbin Capital Partners, L.P. holds 150,886 shares of ROIV stock, worth $1.64 Million. This represents 2.65% of its overall portfolio holdings.
Number of Shares
150,886
Previous 170,886
11.7%
Holding current value
$1.64 Million
Previous $1.81 Million
3.6%
% of portfolio
2.65%
Previous 5.06%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
324Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$718 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$716 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$589 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$454 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$385 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.67B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...